Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial

BACKGROUND: This study evaluated the effects of aclidinium bromide, a long-acting muscarinic antagonist indicated for maintenance treatment of chronic obstructive pulmonary disease (COPD), on exercise endurance, dyspnea, lung hyperinflation, and physical activity. METHODS: In this randomized, double...

Descripción completa

Detalles Bibliográficos
Autores principales: Beeh, Kai M, Watz, Henrik, Puente-Maestu, Luis, de Teresa, Luis, Jarreta, Diana, Caracta, Cynthia, Gil, Esther Garcia, Magnussen, Helgo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364572/
https://www.ncbi.nlm.nih.gov/pubmed/25539654
http://dx.doi.org/10.1186/1471-2466-14-209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364572/
https://www.ncbi.nlm.nih.gov/pubmed/25539654
http://dx.doi.org/10.1186/1471-2466-14-209

Ejemplares similares